Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha FG-GAP repeat containing 2 (ITFG2) is a highly conserved intracellular protein with two FG-GAP domains, which mediate critical protein-protein interactions involved in diverse cellular processes[1][4]. ITFG2 serves as a subunit of the KICSTOR complex, and is a regulator of the amino acid-sensing branch of the mTORC1 signaling pathway; it recruits the GATOR1 complex to lysosomal membranes and allows its interaction with other mTOR regulatory factors, thereby negatively regulating mTORC1 activity in the absence of amino acids or glucose[3][5][8]. ITFG2 also plays key roles in the differentiation and maturation of B cells, immune response modulation, and maintenance of immunoglobulin levels, with additional implications in the development of autoimmune diseases
No specific drug mechanism of action targeting ITFG2 is reported; its regulatory role in mTOR pathway suggests that inhibitors or activators of mTOR pathway might indirectly affect ITFG2 function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha FG-GAP repeat containing 2 (ITFG2).